Table of Content
Introduction
Alpha-1 Antitrypsin Deficiency (A1AD) - Overview
Alpha-1 Antitrypsin Deficiency (A1AD) - Therapeutics Development
Alpha-1 Antitrypsin Deficiency (A1AD) - Therapeutics Assessment
Alpha-1 Antitrypsin Deficiency (A1AD) - Companies Involved in Therapeutics Development
Alpha-1 Antitrypsin Deficiency (A1AD) - Drug Profiles
Alpha-1 Antitrypsin Deficiency (A1AD) - Dormant Projects
Alpha-1 Antitrypsin Deficiency (A1AD) - Discontinued Products
Alpha-1 Antitrypsin Deficiency (A1AD) - Product Development Milestones
Appendix
List of Figures
Number of Products under Development for Alpha-1 Antitrypsin Deficiency (A1AD), H1 2020
Number of Products under Development by Companies, H1 2020
Number of Products by Targets, H1 2020
Number of Products by Stage and Targets, H1 2020
Number of Products by Mechanism of Actions, H1 2020
Number of Products by Stage and Mechanism of Actions, H1 2020
Number of Products by Routes of Administration, H1 2020
Number of Products by Stage and Routes of Administration, H1 2020
Number of Products by Molecule Types, H1 2020
Number of Products by Stage and Molecule Types, H1 2020
List of Tables
Number of Products under Development for Alpha-1 Antitrypsin Deficiency (A1AD), H1 2020
Number of Products under Development by Companies, H1 2020
Number of Products under Development by Universities/Institutes, H1 2020
Products under Development by Companies, H1 2020
Products under Development by Companies, H1 2020 (Contd..1), H1 2020
Products under Development by Universities/Institutes, H1 2020
Number of Products by Stage and Target, H1 2020
Number of Products by Stage and Mechanism of Action, H1 2020
Number of Products by Stage and Route of Administration, H1 2020
Number of Products by Stage and Molecule Type, H1 2020
Alpha-1 Antitrypsin Deficiency (A1AD) - Pipeline by Adverum Biotechnologies Inc, H1 2020
Alpha-1 Antitrypsin Deficiency (A1AD) - Pipeline by Alnylam Pharmaceuticals Inc, H1 2020
Alpha-1 Antitrypsin Deficiency (A1AD) - Pipeline by Apic Bio Inc, H1 2020
Alpha-1 Antitrypsin Deficiency (A1AD) - Pipeline by Applied Genetic Technologies Corp, H1 2020
Alpha-1 Antitrypsin Deficiency (A1AD) - Pipeline by Arrowhead Pharmaceuticals Inc, H1 2020
Alpha-1 Antitrypsin Deficiency (A1AD) - Pipeline by Beam Therapeutics Inc, H1 2020
Alpha-1 Antitrypsin Deficiency (A1AD) - Pipeline by Editas Medicine Inc, H1 2020
Alpha-1 Antitrypsin Deficiency (A1AD) - Pipeline by Evolve Biologics Inc, H1 2020
Alpha-1 Antitrypsin Deficiency (A1AD) - Pipeline by Grifols SA, H1 2020
Alpha-1 Antitrypsin Deficiency (A1AD) - Pipeline by Inhibrx Inc, H1 2020
Alpha-1 Antitrypsin Deficiency (A1AD) - Pipeline by Intellia Therapeutics Inc, H1 2020
Alpha-1 Antitrypsin Deficiency (A1AD) - Pipeline by International Stem Cell Corp, H1 2020
Alpha-1 Antitrypsin Deficiency (A1AD) - Pipeline by Kamada Ltd, H1 2020
Alpha-1 Antitrypsin Deficiency (A1AD) - Pipeline by LEXEO Therapeutics LLC, H1 2020
Alpha-1 Antitrypsin Deficiency (A1AD) - Pipeline by Liminal BioSciences Inc, H1 2020
Alpha-1 Antitrypsin Deficiency (A1AD) - Pipeline by Logicbio Therapeutics Inc, H1 2020
Alpha-1 Antitrypsin Deficiency (A1AD) - Pipeline by Mereo Biopharma Group Plc, H1 2020
Alpha-1 Antitrypsin Deficiency (A1AD) - Pipeline by pH Pharma Co Ltd, H1 2020
Alpha-1 Antitrypsin Deficiency (A1AD) - Pipeline by PlantForm Corp, H1 2020
Alpha-1 Antitrypsin Deficiency (A1AD) - Pipeline by Promethera Biosciences SA, H1 2020
Alpha-1 Antitrypsin Deficiency (A1AD) - Pipeline by Renovion Inc, H1 2020
Alpha-1 Antitrypsin Deficiency (A1AD) - Pipeline by Santhera Pharmaceuticals Holding AG, H1 2020
Alpha-1 Antitrypsin Deficiency (A1AD) - Pipeline by Takeda Pharmaceutical Co Ltd, H1 2020
Alpha-1 Antitrypsin Deficiency (A1AD) - Pipeline by Trucode Gene Repair Inc, H1 2020
Alpha-1 Antitrypsin Deficiency (A1AD) - Pipeline by Vertex Pharmaceuticals Inc, H1 2020
Alpha-1 Antitrypsin Deficiency (A1AD) - Pipeline by Z Factor Ltd, H1 2020
Alpha-1 Antitrypsin Deficiency (A1AD) - Dormant Projects, H1 2020
Alpha-1 Antitrypsin Deficiency (A1AD) - Discontinued Products, H1 2020